Literature DB >> 1868681

Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement.

A B Wymenga1, Y A Hekster, A Theeuwes, H L Muytjens, J R van Horn, T J Slooff.   

Abstract

The amount of additional antibiotics measured by defined daily dose (DDD) methods after 2651 hip and 362 knee replacements was assessed after prophylaxis with one or three doses (1502/1511 patients) of cefuroxime. No differences were observed between the two regimens with respect to total amount, type, indication, and duration of additional antibiotics. The incidence of joint sepsis did not differ significantly between the two trial arms, but the sample was too small for definite conclusions. There were 11.4 DDD/100 bed days of additional antibiotics used in 21% of patients after hip replacement and 15.7 DDD/100 bed days in 31% after knee replacement. For wound problems, 3.8 and 6.9 DDD/100 bed days were given in the hip- and knee-replacement groups. For distant infection, 6.5 DDD/100 bed days was administered in both groups. Duration of therapy varied only in relation to indication. Prescribed were penicillins (43% to 50%), sulfonamides (18%), cephalosporins (10% to 16%), and nitrofurantoin (8% to 13%); drug use was related to the type of infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868681     DOI: 10.1038/clpt.1991.127

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Postoperative antibiotic prophylaxis in total hip and knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Patrick Thornley; Nathan Evaniew; Michael Riediger; Mitchell Winemaker; Mohit Bhandari; Michelle Ghert
Journal:  CMAJ Open       Date:  2015-07-17

2.  [Results before and after introduction of perioperative antibiotic prophylaxis in hip joint prostheses treatment of geriatric patients].

Authors:  W Kaiser; V Gulielmos; H Hausmann; S Ghalehasadi
Journal:  Unfallchirurgie       Date:  1996-08

3.  Is There a Difference in Infection Risk Between Single and Multiple Doses of Prophylactic Antibiotics? A Meta-analysis.

Authors:  Sean P Ryan; Beau J Kildow; Timothy L Tan; Javad Parvizi; Michael P Bolognesi; Thorsten M Seyler
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

4.  Deep infection after primary hip arthroplasty: results after treatment of 10 patients.

Authors:  M Breddam; T B Hansen; P B Thomsen
Journal:  Eur J Orthop Surg Traumatol       Date:  1996-05

5.  The AAHKS Clinical Research Award: Extended Oral Antibiotics Prevent Periprosthetic Joint Infection in High-Risk Cases: 3855 Patients With 1-Year Follow-Up.

Authors:  Michael M Kheir; Julian E Dilley; Mary Ziemba-Davis; R Michael Meneghini
Journal:  J Arthroplasty       Date:  2021-01-23       Impact factor: 4.435

6.  Postoperative prophylactic antibiotics in total joint arthroplasty.

Authors:  Adolph J Yates
Journal:  Arthroplast Today       Date:  2018-02-14

7.  Non-inferior comparative study comparing one or two day antimicrobial prophylaxis after clean orthopaedic surgery (NOCOTA study): a study protocol for a cluster pseudo-randomized controlled trial comparing duration of antibiotic prophylaxis.

Authors:  Kosei Nagata; Koji Yamada; Tomohiro Shinozaki; Tsuyoshi Miyazaki; Fumiaki Tokimura; Hiroyuki Oka; Yasuhito Tajiri; Sakae Tanaka; Hiroshi Okazaki
Journal:  BMC Musculoskelet Disord       Date:  2019-11-13       Impact factor: 2.362

8.  Effect of Antimicrobial Prophylaxis Duration on Health Care-Associated Infections After Clean Orthopedic Surgery: A Cluster Randomized Trial.

Authors:  Kosei Nagata; Koji Yamada; Tomohiro Shinozaki; Tsuyoshi Miyazaki; Fumiaki Tokimura; Yasuhito Tajiri; Takuya Matsumoto; Kiyofumi Yamakawa; Hiroyuki Oka; Akiro Higashikawa; Toshihide Sato; Kenichi Kawano; Tatsuro Karita; Takuya Koyama; Takahiro Hozumi; Hiroaki Abe; Makoto Hodohara; Kazuhiro Kohata; Masato Toyonaga; Yasushi Oshima; Sakae Tanaka; Hiroshi Okazaki
Journal:  JAMA Netw Open       Date:  2022-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.